Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-isoleucine for Hot Flashes
NCT00081952Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Oct 2003
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Isoleucine in hot flashes (2 arms), sponsored by National Center for Complementary and Integrative Health. Primary endpoints: Frequency of Hot Flashes at 10 weeks and Severity of Hot Flashes at 10 weeks. Started Oct 2003; status: completed.
02
Drugs
Isoleucine
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT00081952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081952.